Age (years) | 15 | 14 | 45 | 25 | 33 |
Gender | Female | Female | Male | Female | Female |
Ingestion amount (mL) | 150 | 100 | 110 | 90 | 100 |
Poisoning to admission time (hours) | 4 | 24 | 24 | 24 | 10 |
Hospital stays (hours) | 58.0 | 79.0 | 72.5 | 365.5 | 298.0 |
CRRT/HP | HP | HP | HP+CRRT | CRRT | HP+CRRT |
Clinical manifestations before ECMO | | | | | |
Dyspnea | No | Yes | Yes | Yes | Yes |
SaO2 (%) | 97.8 | 60.5 | 88.1 | 92.0 | 70.0 |
Creatinine (μmol/L) | 243 | 464 | 354 | 120 | 296 |
PaO2 (mmHg) | 112 | 33 | 53 | 60 | 37 |
pH | 7.40 | 7.44 | 7.45 | 7.45 | 7.45 |
WBC (×109/L) | 16.6 | 9.2 | 33.9 | 6.7 | 16.6 |
APACHE II score | 11 | 28 | 15 | 8 | 12 |
CT scanning | No abnormality | Bilateral pulmonary multiple patchy blur | Bilateral pulmonary interstitial fibrosis | Bilateral pulmonary multiple patchy shadows with partial consolidation; bilateral pleural effusion | Bilateral pulmonary diffuse patchy shadows |
Indications of ECMO | Circulatory failure | Cardiopulmonary failure | Respiratory failure | Respiratory failure | Respiratory failure |
ECMO characteristics | | | | | |
Poisoning to ECMO time (hours) | 21 | 96 | 72 | 144 | 72 |
ECMO pattern | V-A | V-A | V-V | V-V | V-V |
Bypass | LFA-LFV | RFA-LFV | RFV-RJV | RFV-RJV | RFV-RJV |
ECMO complications | Hemorrhage at puncture point | Hemorrhagic shock | Oropharyngeal hemorrhage | No | Multiple organ hemorrhage |
ECMO to death time (hours) | 41.0 | 7.0 | 24.5 | 245.5 | 236.0 |
Death reasons | MOF | Hemorrhagic shock | MOF | Respiratory failure, giving up treatment | MOF, giving up treatment |